GLP-1 drugs like Novo Nordisk's Victoza are a major advance in the treatment of diabetes, a condition suffered by hundreds of millions of people worldwide. KristineHarjes: That suggests that a ...

A woman who’s been on a drug similar to Ozempic for nearly a decade is sharing what she’s learned. Danielle Payton, 33, is believed to be one of the longest-serving patients on a GLP-1 injection. The ...

Novo Nordisk's (NVO) new type-2 diabetes drug Victoza is rapidly gaining market share in the all-important U.S. market. The Danish drug maker's early commercial success with its subcutaneous "GLP-1" ...

PLAINSBORO, N.J., Aug. 25, 2017 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza ® (liraglutide) to reduce the risk of major adverse cardiovascular ...

Branded content furnished by our promotional partners. The Daily Sundial editorial staff is not involved in its production. Content does not reflect the views or opinions of the editorial staff.

In mid-April this year, Novo Nordisk obtained the State Food and Drug Administration (SFDA) approval for Victoza (liraglutide recombinant), an injectable treatment for type II diabetes; it plans to ...

How can a new Type 2 diabetes drug compete? Take a look at Novo Nordisk's plans for marketing its newcomer Victoza. Medical Marketing & Media reports that Novo reps are in workshops now, prepping for ...

Victoza, originally approved by the FDA in 2010 for diabetes, is part of the same class of drugs that includes Ozempic, Wegovy, and Zepbound. Experts say they welcome the generic formulation but ...

greater improvements in mean HbA1c (a measure of blood glucose levels) (-1.05% vs. -0.38%; ETD -0.66% [95% CI: -0.90;-0.43]; p<0.0001), were more likely to achieve target HbA1c <7% (52.8% vs. 19.5%; ...

Liraglutide is an injectable prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes ...